These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38512353)

  • 21. Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinoma.
    Liang J; Sun G; Pan X; Zhang M; Shen P; Zhu S; Zhao J; Zheng L; Zhao J; Chen Y; Yin X; Chen J; Hu X; Zeng Y; Chen J; Wang Y; Liu Z; Yao J; Su M; Huang R; Liao B; Wei Q; Li X; Zhou Q; Liu J; Shen Y; Liu Z; Chen N; Zeng H; Zhang X
    Genome Med; 2023 May; 15(1):31. PubMed ID: 37131267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancer.
    Bell HN; Kumar-Sinha C; Mannan R; Zakalik D; Zhang Y; Mehra R; Jagtap D; Dhanasekaran SM; Vaishampayan U
    Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic acinar cell carcinoma is associated with
    Kryklyva V; Haj Mohammad N; Morsink FHM; Ligtenberg MJL; Offerhaus GJA; Nagtegaal ID; de Leng WWJ; Brosens LAA
    Cancer Biol Ther; 2019; 20(7):949-955. PubMed ID: 31002019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
    Malouf GG; Ali SM; Wang K; Balasubramanian S; Ross JS; Miller VA; Stephens PJ; Khayat D; Pal SK; Su X; Sircar K; Tamboli P; Jonasch E; Tannir NM; Wood CG; Karam JA
    Eur Urol; 2016 Aug; 70(2):348-57. PubMed ID: 26895810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline mutations in cancer-predisposition genes in patients with biliary tract cancer.
    Terashima T; Umemoto K; Takahashi H; Hosoi H; Takai E; Kondo S; Sakamoto Y; Mitsunaga S; Ohno I; Hashimoto Y; Sasaki M; Ikeda M; Shimada K; Kaneko S; Yachida S; Sugano K; Okusaka T; Morizane C
    Oncotarget; 2019 Oct; 10(57):5949-5957. PubMed ID: 31666926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.
    Gleeson JP; Nikolovski I; Dinatale R; Zucker M; Knezevic A; Patil S; Ged Y; Kotecha RR; Shapnik N; Murray S; Russo P; Coleman J; Lee CH; Stadler ZK; Hakimi AA; Feldman DR; Motzer RJ; Reznik E; Voss MH; Chen YB; Carlo MI
    Clin Cancer Res; 2021 May; 27(10):2910-2919. PubMed ID: 33658299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors.
    Tworek H; Peng R; Fetzer S; Werness BA; Piver MS; Allen HJ; DiCioccio RA
    Cancer Genet Cytogenet; 1999 Jul; 112(2):105-18. PubMed ID: 10686936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
    Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
    Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
    Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR
    Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice.
    Dong A; Lu Y; Lu B
    J Cancer; 2016; 7(11):1441-51. PubMed ID: 27471560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hereditary kidney cancers: The pathologist's view in 2020].
    Verkarre V; Morini A; Denize T; Ferlicot S; Richard S
    Ann Pathol; 2020 Apr; 40(2):148-167. PubMed ID: 32197858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary kidney cancer: unique opportunity for disease-based therapy.
    Linehan WM; Pinto PA; Bratslavsky G; Pfaffenroth E; Merino M; Vocke CD; Toro JR; Bottaro D; Neckers L; Schmidt LS; Srinivasan R
    Cancer; 2009 May; 115(10 Suppl):2252-61. PubMed ID: 19402075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations.
    Kim J; Jeong K; Jun H; Kim K; Bae JM; Song MG; Yi H; Park S; Woo GU; Lee DW; Kim TY; Lee KH; Im SA
    Hum Genomics; 2023 Jan; 17(1):2. PubMed ID: 36604691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes.
    Stefansson OA; Jonasson JG; Johannsson OT; Olafsdottir K; Steinarsdottir M; Valgeirsdottir S; Eyfjord JE
    Breast Cancer Res; 2009; 11(4):R47. PubMed ID: 19589159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
    Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
    Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma.
    Feng H; Cao S; Ouyang Q; Li H; Li X; Chen K; Zhang X; Huang Y; Zhang X; Ma X
    Transl Androl Urol; 2023 Feb; 12(2):308-319. PubMed ID: 36915884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
    Silva FC; Lisboa BC; Figueiredo MC; Torrezan GT; Santos EM; Krepischi AC; Rossi BM; Achatz MI; Carraro DM
    BMC Med Genet; 2014 May; 15():55. PubMed ID: 24884479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.
    Welcsh PL; King MC
    Hum Mol Genet; 2001 Apr; 10(7):705-13. PubMed ID: 11257103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary leiomyomatosis and renal cell cancer without cutaneous manifestations in two Japanese siblings.
    Noguchi G; Furuya M; Okubo Y; Nagashima Y; Kato I; Matsumoto K; Tanaka R; Hisasue SI; Yao M; Kishida T
    Int J Urol; 2018 Sep; 25(9):832-835. PubMed ID: 30058172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.